Common medications and prostate cancer mortality: a review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/article/10.1007/s00345-016-1912-5/fulltext.html
Reference60 articles.
1. Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF (2013) Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 158(10):709–717. doi: 10.7326/0003-4819-158-10-201305210-00005
2. Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673–683. doi: 10.1038/nrd1468
3. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL (2015) Trends in prescription drug use among adults in the United States from 1999–2012. JAMA 314(17):1818–1831. doi: 10.1001/jama.2015.13766
4. Neuhouser ML, Kristal AR, Patterson RE, Goodman PJ, Thompson IM (2001) Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials. Nutr Cancer 39(1):12–18. doi: 10.1207/S15327914nc391_2
5. Grainger EM, Kim HS, Monk JP, Lemeshow SA, Gong M, Bahnson RR, Clinton SK (2008) Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center. Urol Oncol 26(2):125–132. doi: 10.1016/j.urolonc.2007.01.016
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Editorial Comment;Journal of Urology;2022-09
2. Regular, Long-Duration Multivitamin Use and Risk of Overall and Aggressive Prostate Cancer in the Health Professionals Follow-Up Study;Journal of Urology;2022-09
3. ELOVL2 restrains cell proliferation, migration, and invasion of prostate cancer via regulation of the tumor suppressor INPP4B;Cellular Signalling;2022-08
4. Statins and prostate cancer—hype or hope? The epidemiological perspective;Prostate Cancer and Prostatic Diseases;2022-06-22
5. Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study;Breast Cancer Research and Treatment;2021-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3